Regeneron Pharmaceuticals (REGN)
R&D Expense Growth
-0.84%
Quarterly · Period ending:
REGN R&D Expense Growth
Latest reported-0.84%period ending
Latest reported-0.84%period ending
REGN Quarterly R&D Growth (QoQ) (0.00% → -0.84%)
Latest values, visible window
High-resolution chart · PNG
REGN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 16.6082% | |
| 6.4551% | |
| 12.0767% | |
| -2.2554% | |
| 20.334% | |
| 20.9596% | |
| -23.2558% | |
| 19.4444% | |
| -3.5714% | |
| 13.1313% | |
| 0% | |
| 8.7912% | |
| 10.9756% | |
| 17.1429% | |
| 2.9412% | |
| -1.4493% | |
| -2.8169% | |
| 2.8986% | |
| -10.3896% | |
| 13.2353% | |
| -1.4493% | |
| 15% | |
| 5.2632% | |
| -1.7241% | |
| 0% | |
| -36.2637% | |
| -4.2105% | |
| -7.767% | |
| -4.6296% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |